Results 101 to 110 of about 33,479 (238)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

, 2016
Johannes Baur,1 Christian O Ritter,2 Christoph-Thomas Germer,1 Ingo Klein,1 Ralph Kickuth,2 Ulrich Steger,1 1Department of General, Visceral, Vascular, and Pediatric Surgery, 2Institute of Radiology, University Hospital Würzburg, Würzburg ...
Germer CT, Ritter CO, Baur J, Kickuth R, Klein I, Steger U   +5 more
core  

Complications of chemoembolization for hepatic neoplasms

Saudi Medical Journal, 2007
OBJECTIVE: To present a safe and effective approach to chemoembolization for hepatic neoplasms, and to discuss the complications of chemoembolization and ways of avoiding them. METHODS: The techniques and experience described herein are based on clinical practice at Yichang Central People9s Hospital, Yichang, Hubei, China, where over 200 ...
Hongxiu, Dai, Hui, Ding, Faquan, Liu, Zhenjiu, Yao, Lina, Li, Chuang, Li, Yiqing, Tan, Jun, Wang   +7 more
openaire   +2 more sources

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia

American Journal of Hematology, Volume 101, Issue 10, Page 2571-2580, October 2026.
ABSTRACT Chronic liver disease (CLD)‐related thrombocytopenia can limit the feasibility of invasive procedures. Recombinant human thrombopoietin (rhTPO) has demonstrated a favorable safety profile without hepatotoxicity. We evaluated the efficacy and safety of rhTPO in patients with CLD‐related thrombocytopenia who were undergoing elective invasive ...
Yifan Han, Ning Lin, Jinghang Xu, Sikui Wang, Jinglan Jin, Jia Shang, Yongning Xin, Youwen Tan, Dazhi Zhang, Jinlin Hou, Ping An, Wen Xie, Yujuan Guan, Qingfang Xiong, Hong Wu, Huiguo Ding, Yu Chen, Rongkuan Li, Zhili Wen, Mingqin Lu, Jinhui Yang, Zhongyin Zhou, Yongjian Zhou, Zujiang Yu, Kecan Lin, Wei Wang, Yan Huang, Yuemin Nan, Xinhua Luo, Rongshu Shi, Yi Kang, Tao Han, Shiyan Chen, Kai Wang, Yunfeng Shan, Jiaping Li, Pingguo Liu, Zheng Lu, Jun Chen, Zhen Liu, Liaoyun Zhang, Li Yang, Jifang Sheng, Zhan Zeng, Yanyan Yu, Xiaoyuan Xu   +45 more
wiley   +1 more source

Construction of a Non‐Invasive Predictive Model Based on PIVKA‐II Combined With MRI Imaging Features for Evaluating Microvascular Invasion in Hepatocellular Carcinoma

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 10, October 2026.
ABSTRACT This study developed a non‐invasive model using PIVKA‐II and MRI features to predict microvascular invasion in hepatocellular carcinoma, providing a reliable tool for early risk assessment and personalized treatment planning. The study included 98 patients with pathologically confirmed HCC (Child‐Pugh A, BCLC stage A), comprising 43 MVI ...
Di Gao, Rui‐Qi Jin, Hong‐Wei Wang
wiley   +1 more source

Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis

, 2016
Qianqian Zhao,1,2 Kunli Zhu,2 Jinbo Yue,2 Zhonghua Qi,1,2 Shumei Jiang,2 Xiaoqing Xu,2 Rui Feng,2 Renben Wang2 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 2Department of Radiation Oncology, Shandong ...
Qi Z, Wang R, Zhao Q, Zhu K, Jiang S, Xu X, Feng R, Yue J   +7 more
core  

Effect of Mixing Methods on the Characteristics of N-Butyl-2-Cyanoacrylate and Ethiodized Oil Mixtures

Journal of the Korean Society of Radiology
Purpose This study aims to evaluate the effects of different mixing techniques on the characteristics of n-butyl-2-cyanoacrylate (NBCA) and ethiodized oil mixtures.
Hooney D. Min, Gyu Suk Nam, Chong-ho Lee, Kun Yung Kim, Minuk Kim, Chang Jin Yoon, Sung-Hwan Yoon, Jae Hwan Lee   +7 more
doaj   +1 more source

Transarterial Chemoembolization for Hepatocellular Carcinoma [PDF]

Seminars in Interventional Radiology, 2009
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is responsible for ~500,000 deaths worldwide annually.1 The incidence almost equals the mortality. It is the most common cause of death in patients with compensated liver cirrhosis. HCC usually arises in the setting of chronic liver disease, commonly from hepatitis B, C,
openaire   +2 more sources

Perioperative Camrelizumab and Apatinib for High‐Risk Resectable Hepatocellular Carcinoma: A Phase II Study

MedComm, Volume 7, Issue 10, October 2026.
In this study, perioperative camrelizumab plus apatinib demonstrated promising efficacy and safety in resectable hepatocellular carcinoma (HCC) patients at high risk of recurrence, achieving a major pathological response of 46.2%. The median disease‐free survival and progression‐free survival were 24.1 months and 18.3 months, respectively.
Yunlong Cui, Xu Bao, Ge Yu, Feng Fang, Qiang Li, Han Mu, Chen Liu, Qiang Wu, Wei Zhang, Huikai Li, Ping Chen, Xiaomeng Liu, Hongyuan Zhou, Tianqiang Song   +13 more
wiley   +1 more source

Detection of Recurrent/Residual Hepatocellular Carcinoma: Single-Center Retrospective Comparative Study Between Parenchymal Blood Volume Mapping Using Cone Beam CT and Multiphase Dynamic CT

대한영상의학회지, 2018
Purpose: To evaluate the usefulness of cone beam computed tomography (CT)- based parenchymal blood volume (PBV) mapping for the detection of marginal recurrence or residual hepatocellular carcinoma, after transcatheter arterial chemoembolization (TACE),
Na Rae Kim, Ji Dae Kim, Hyun Young Han, Hee Jin Kim   +3 more
doaj   +1 more source

CHEMOEMBOLIZATION FOR UNRESECTABLE COLORECTAL LIVER METASTASES WITH DRUG-ELUTING MICROSPHERES

Вестник рентгенологии и радиологии, 2016
Objective: to evaluate the efficiency of chemoembolization using irinotecan-loaded DC Bead microspheres in the second-line chemotherapy for colorectal liver metastases.Material and methods.
A. V. Skupchenko, A. V. Lysenko, D. G. Korolev, D. A. Skobel’tsov, A. S. Rassudishkin   +4 more
doaj   +1 more source